Gamma-Aminobutyric Acid Receptor, Type A (GABA-AR) Antibody, IgG by CBA-IFA with Reflex to Titer, CSF
Also known as: GABA-A CSF
Use
Aids in the diagnosis of limbic encephalitis and autoimmune epilepsy. May be used to monitor treatment response in individuals who are antibody positive. The presence of GABA-AR antibodies may be associated with refractory seizures, memory loss, behavior changes, abnormal movements, and decreased level of consciousness. GABA-AR encephalitis may be paraneoplastic, but tumor type is variable (e.g., thymoma, small cell lung cancer, rectal cancers, and hematologic malignancy). GABA-AR encephalitis may also be associated with post-viral and autoimmune diseases.
Special Instructions
If GABA-AR antibody IgG is positive, then GABA-AR antibody IgG titer will be added. Additional charges apply.
Limitations
A negative test result does not rule out a diagnosis of autoimmune limbic encephalitis or autoimmune epilepsy. Interpretation of any antineural antibody test requires clinical correlation.
Methodology
Other
Biomarkers
LOINC Codes
- 103715-9
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
0.5 mL
Minimum Volume
0.15 mL
Container
ARUP standard transport tube
Causes for Rejection
Grossly hemolyzed or contaminated specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 month (Three freeze/thaw cycles are acceptable) |
Other tests from different labs that may be relevant
